A research and development and licensing arrangement under which MEDIPAL HOLDINGS CORPORATION bears part of the research and development costs and the Company pays royalties on the 2 products concerned. This covers the specific funding and joint commercialization framework with MEDIPAL HOLDINGS CORPORATION, including the overseas commercialization of JR-479 and joint development and commercialization agreements in Japan.